Market Overview - The Hong Kong stock market is experiencing a shift in capital flow, moving from growth to a more defensive positioning amid a collective decline in the three major indices [1] - On October 28, the market failed to maintain the previous day's gains, with a trading volume of 242.7 billion HKD, indicating a cautious investor sentiment [1] Sector Performance - The gold sector faced significant declines, with multiple stocks experiencing steep drops: China Silver Group fell over 10%, Lingbao Gold down 5.74%, and Zijin Mining down 5.59% [3] - The drop in gold stocks is closely linked to the international gold price, which fell 3.05% on October 27, dropping below 3990 USD per ounce [3] - The new consumption sector, once favored, is now seeing substantial outflows, with leading stocks like Pop Mart down over 32% from their historical highs [6] - The technology sector also showed weakness, with major stocks like NetEase and Meituan declining by 2.35% and 1.96% respectively [8] Capital Flow - There has been a notable shift in capital flow, with southbound funds moving from net inflows to significant outflows in the consumer sector, redirecting towards technology and healthcare [8] - Despite the overall market downturn, local bank and insurance stocks performed well, with HSBC rising 4.41% due to better-than-expected quarterly results [10] Investment Sentiment - The market is witnessing a rotation from high-growth, high-valuation sectors to defensive assets, reflecting a change in investor risk appetite [10] - Continuous inflows from southbound funds, totaling 2.258 billion HKD on October 28, indicate mainland investors' recognition of the long-term value in Hong Kong stocks [12] Economic Outlook - Analysts suggest that potential interest rate cuts by the Federal Reserve and a depreciating USD alongside an appreciating RMB could support the valuation of Chinese assets, benefiting the Hong Kong market [14] - The significant pullback in gold stocks and the weakness in consumer stocks illustrate a clear picture of declining risk appetite in the current market environment [14]

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on October 28, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent. Group 1: Buyback Details - China Feihe (06186) repurchased 5.174 million shares for a total of 21.6293 million yuan, representing 0.209% of its total share capital [1][2] - Lianyi Rong Technology (09959) repurchased 1.4625 million shares for 4.7622 million yuan, accounting for 3.638% of its total share capital [2] - Zhongxu Future (09890) repurchased 301,400 shares for 4.4130 million yuan, which is 1.270% of its total share capital [2] Group 2: Other Notable Buybacks - Mengniu Dairy (02319) repurchased 300,000 shares for 4.2977 million yuan, representing 0.563% of its total share capital [2] - Jitu Express (01519) repurchased 385,000 shares for 3.8812 million yuan, which is 0.014% of its total share capital [2] - Kangning Jereh Pharmaceutical (09966) repurchased 320,000 shares for 3.7683 million yuan, accounting for 0.117% of its total share capital [2] Group 3: Additional Companies Involved - Other companies involved in the buyback include: - Guichuang Tongqiao-B (02190) with 50,000 shares repurchased for 1.2065 million yuan [2] - Green City Services (02869) with 208,000 shares repurchased for 969,700 yuan [2] - Tianfu (06868) with 2,000 shares repurchased for 60,400 yuan [3]

歌礼制药-B(01672)发布公告，于2025年10月28日，该公司斥资91.89万港元回购10万股股份，每股回购 价格为9.14-9.31港元。 ...

智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年10月28日，该公司斥资91.89万港元回购10万 股股份，每股回购价格为9.14-9.31港元。 ...

格隆汇10月28日丨歌礼制药-B(01672.HK)发布公告，2025年10月28日耗资91.89万港元回购10万股，回 购价格每股9.14-9.31港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 歌禮製藥有限公司 呈交日期： 2025年10月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 FF305 第 2 頁 共 7 頁 v 1.3.0 FF305 確認 不適用 第一章節註釋： | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01672 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫 ...

Market Performance - A-shares opened higher with the Shanghai Composite Index rising by 1.18% to 3996.94 points, Shenzhen Component up 1.51%, and ChiNext Index up 1.98%[1] - Hong Kong's Hang Seng Index closed up 1.05% at 26433.7 points, with the Hang Seng Tech Index increasing by 1.83% and the Hang Seng China Enterprises Index up 1.1%[1] - The total market turnover reached 2670.772 million HKD[1] Economic Developments - The People's Bank of China announced the resumption of government bond trading operations, with analysts expecting a quick restart to stabilize bond supply and demand[1][12] - The EU and China are set to discuss temporary allowances for semiconductor exports, particularly concerning Nexperia's operations in China[12] Sector Highlights - Lithium battery and semiconductor sectors led the gains in the A-share market[1] - The semiconductor sector showed a strong rebound, while non-ferrous metals also strengthened[1] International Market Trends - US stock indices all closed higher, with the Dow Jones up 0.71%, S&P 500 up 1.23%, and Nasdaq up 1.86%[1] - European stock indices also saw slight increases, reflecting a positive sentiment in global markets[1]

Summary of Key Points Core Viewpoint - On October 27, 34 Hong Kong-listed companies conducted share buybacks, totaling 15.35 million shares and an aggregate amount of HKD 76.77 million, indicating a trend of companies returning capital to shareholders through buybacks [1]. Group 1: Buyback Details - China Feihe repurchased 5.89 million shares for HKD 24.07 million, with a highest price of HKD 4.09 and a lowest price of HKD 4.08, accumulating HKD 57.07 million in buybacks for the year [1][2]. - Gushengtang repurchased 244,400 shares for HKD 7.19 million, with a highest price of HKD 29.66 and a lowest price of HKD 29.22, totaling HKD 256.39 million in buybacks for the year [1][2]. - Mengniu Dairy repurchased 400,000 shares for HKD 5.77 million, with a highest price of HKD 14.46 and a lowest price of HKD 14.38, accumulating HKD 480 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 27 was by China Feihe at HKD 24.07 million, followed by Gushengtang at HKD 7.19 million, and Mengniu Dairy among the top [1][2]. - In terms of share quantity, China Feihe led with 5.89 million shares repurchased, followed by Chenxun Technology and Lianyi Technology-W with 1.45 million and 1.16 million shares, respectively [1][2]. Group 3: Additional Buyback Information - The buyback by Puleshi Group Holdings was noted as its first for the year, while Mengniu Dairy has conducted multiple buybacks totaling HKD 480 million [2]. - A detailed table of buybacks on October 27 includes various companies, their respective buyback shares, amounts, highest and lowest prices, and cumulative buyback amounts for the year [2][3].

Summary of Key Points Core Viewpoint - A total of 30 companies conducted share buybacks on October 27, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent on buybacks. Group 1: Buyback Details - China Feihe (06186) repurchased 5.886 million shares for a total of 24.0721 million yuan, representing 0.152% of its total share capital with a year-to-date total of 13.771 million shares repurchased [1][2] - Guosheng Tang (02273) repurchased 244,400 shares for 7.1899 million yuan, with a year-to-date total of 5.5026 million shares, accounting for 2.322% of its total share capital [2] - Mengniu Dairy (02319) repurchased 400,000 shares for 5.7710 million yuan, with a year-to-date total of 21.716 million shares, representing 0.555% of its total share capital [2] Group 2: Other Notable Buybacks - Lianlian Digital (02598) repurchased 711,000 shares for 5.7458 million yuan, with a year-to-date total of 2.5925 million shares, accounting for 0.620% of its total share capital [2] - Zhongxu Future (09890) repurchased 345,200 shares for 5.0690 million yuan, with a year-to-date total of 647,400 shares, representing 1.210% of its total share capital [2] - Kangchen Pharmaceutical (01681) repurchased 100,000 shares for 1.5400 million yuan, with a year-to-date total of 740,600 shares, accounting for 8.700% of its total share capital [2][3]

歌礼制药-B(01672)发布公告，于2025年10月27日该公司斥资约97万港元回购10万股，回购价格为每股 9.58-9.73港元。 ...